Evidence map›Paper›PMID 32427830›Full record

ArticleTranslational psychiatry2020

Improved metabolomic data-based prediction of depressive symptoms using nonlinear machine learning with feature selection.

Yuta Takahashi, Masao Ueki, Makoto Yamada, Gen Tamiya, Ikuko N Motoike, Daisuke Saigusa, Miyuki Sakurai, Fuji Nagami, Soichi Ogishima, Seizo Koshiba and 3 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Variation of DNA methylation on theRegenerative therapy · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Yuta TakahashiGraduate School of Medicine, Tohoku University, Sendai, Japan. yuta.takahashi@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0002-6996-3505
Masao UekiTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Makoto YamadaRIKEN Center for Advanced Intelligence Project, Tokyo, Japan.
Gen TamiyaGraduate School of Medicine, Tohoku University, Sendai, Japan.
Ikuko N MotoikeTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Daisuke SaigusaGraduate School of Medicine, Tohoku University, Sendai, Japan.
Miyuki SakuraiTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Fuji NagamiTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Soichi OgishimaGraduate School of Medicine, Tohoku University, Sendai, Japan.
Seizo KoshibaGraduate School of Medicine, Tohoku University, Sendai, Japan.
Kengo KinoshitaTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.ORCID http://orcid.org/0000-0003-3453-2171
Masayuki YamamotoGraduate School of Medicine, Tohoku University, Sendai, Japan.
Hiroaki TomitaGraduate School of Medicine, Tohoku University, Sendai, Japan. htomita@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0003-2628-880X
Tohoku University · JPRIKEN Center for Advanced Intelligence Project · JPTohoku Institute of Technology · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP19dm0107099
6 · The paper itself

Abstract

To solve major limitations in algorithms for the metabolite-based prediction of psychiatric phenotypes, a novel prediction model for depressive symptoms based on nonlinear feature selection machine learning, the Hilbert-Schmidt independence criterion least absolute shrinkage and selection operator (HSIC Lasso) algorithm, was developed and applied to a metabolomic dataset with the largest sample size to date. In total, 897 population-based subjects were recruited from the communities affected by the Great East Japan Earthquake; 306 metabolite features (37 metabolites identified by nuclear magnetic resonance measurements and 269 characterized metabolites based on the intensities from mass spectrometry) were utilized to build prediction models for depressive symptoms as evaluated by the Center for Epidemiologic Studies-Depression Scale (CES-D). The nested fivefold cross-validation was used for developing and evaluating the prediction models. The HSIC Lasso-based prediction model showed better predictive power than the other prediction models, including Lasso, support vector machine, partial least squares, random forest, and neural network. L-leucine, 3-hydroxyisobutyrate, and gamma-linolenyl carnitine frequently contributed to the prediction. We have demonstrated that the HSIC Lasso-based prediction model integrating nonlinear feature selection showed improved predictive power for depressive symptoms based on metabolome data as well as on risk metabolites based on nonlinear statistics in the Japanese population. Further studies should use HSIC Lasso-based prediction models with different ethnicities to investigate the generality of each risk metabolite for predicting depressive symptoms.

Indexed as

DepressionMachine LearningAlgorithmsDatabases, FactualJapan

Identifiers

PMID32427830
PMCPMC7237664
OpenAlexW3027945570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.